[go: up one dir, main page]

Bhanoori et al., 2005 - Google Patents

The vascular endothelial growth factor (VEGF)+ 405G> C 5′-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case …

Bhanoori et al., 2005

View HTML
Document ID
8536793080654639001
Author
Bhanoori M
Arvind Babu K
Pavankumar Reddy N
Lakshmi Rao K
Zondervan K
Deenadayal M
Kennedy S
Shivaji S
Publication year
Publication venue
Human Reproduction

External Links

Snippet

BACKGROUND: Vascular endothelial growth factor (VEGF), a major mediator of angiogenesis and vascular permeability, is known to play a key role in the pathophysiology of endometriosis. METHODS AND RESULTS: The single nucleotide polymorphisms …
Continue reading at academic.oup.com (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Similar Documents

Publication Publication Date Title
Bhanoori et al. The vascular endothelial growth factor (VEGF)+ 405G> C 5′-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study
Lamp et al. Polymorphisms in ESR1, ESR2 and HSD17B1 genes are associated with fertility status in endometriosis
Lee et al. Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome
Kim et al. Vascular endothelial growth factor gene+ 405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis
Valkenburg et al. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome
Hsieh et al. Estrogen receptor α-351 Xba I* G and-397 Pvu II* C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma
Kado et al. Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women
Terry et al. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk
Andersson et al. DNA methylation of HOXA10 in eutopic and ectopic endometrium
Wu et al. Association between FSHR polymorphisms and polycystic ovary syndrome among Chinese women in north China
Siddamalla et al. Vitamin D receptor gene polymorphisms and risk of polycystic ovary syndrome in South Indian women
Van Kaam et al. Progesterone receptor polymorphism+ 331G/A is associated with a decreased risk of deep infiltrating endometriosis
Palit et al. A genetic analysis identifies a haplotype at adiponectin locus: association with obesity and type 2 diabetes
Baxter et al. Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin α genes
Westerveld et al. Mutations in the testis-specific NALP14 gene in men suffering from spermatogenic failure
Kang et al. Association between genetic polymorphisms in fibroblast growth factor (FGF) 1 and FGF2 and risk of endometriosis and adenomyosis in Chinese women
Renner et al. Evaluation of clinical parameters and estrogen receptor alpha gene polymorphisms for patients with endometriosis
Dun et al. Advances in the genetics of endometriosis
Fung et al. The genetic regulation of transcription in human endometrial tissue
Liu et al. Association of polymorphisms− 1154G/A and− 2578C/A in the vascular endothelial growth factor gene with decreased risk of endometriosis in Chinese women
Kim et al. Uteroglobin gene polymorphisms affect the progression of immunoglobulin A nephropathy by modulating the level of uteroglobin expression
Gentilini et al. The vascular endothelial growth factor+ 405G> C polymorphism in endometriosis
Hadziselimovic et al. Deficient expression of genes involved in the endogenous defense system against transposons in cryptorchid boys with impaired mini-puberty
Juo et al. CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women
Wang et al. CYP19 gene variant confers susceptibility to endometriosis-associated infertility in Chinese women